ArticleVaccine2024

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023.

Ian D Plumb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.